Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Azusa Hoshina"'
Autor:
Hiraku Tsujimoto, Azusa Hoshina, Shin-Ichi Mae, Toshikazu Araoka, Wang Changting, Yoshihiro Ijiri, May Nakajima-Koyama, Satoko Sakurai, Kazusa Okita, Ken Mizuta, Akira Niwa, Megumu K. Saito, Mitinori Saitou, Takuya Yamamoto, Cecilia Graneli, Kevin J. Woollard, Kenji Osafune
Publikováno v:
Cell Reports, Vol 43, Iss 2, Pp 113602- (2024)
Summary: Recent regenerative studies using human pluripotent stem cells (hPSCs) have developed multiple kidney-lineage cells and organoids. However, to further form functional segments of the kidney, interactions of epithelial and interstitial cells
Externí odkaz:
https://doaj.org/article/0ff925a8f95745d09e7a299bf70b6721
Autor:
Azusa Hoshina, Shuichiro Endo
Publikováno v:
CEN Case Rep
Immune checkpoint inhibitors (ICIs) have become the standard treatment for many types of cancer and have improved patient prognosis. However, ICIs upregulate the immune system against tumors, leading to immune-related adverse events (irAEs). Kidney i
Autor:
Hiromi Tanaka, Shin Ichi Sueta, Azusa Hoshina, Kenji Osafune, Yukiko Yamagishi, Shin Ichi Mae, Toshikazu Araoka, Tatsuya Kawamoto, Yasunori Sato
Publikováno v:
Scientific Reports, Vol 9, Iss 1, Pp 1-4 (2019)
A correction to this article has been published and is linked from the HTML and PDF versions of this paper. The error has not been fixed in the paper.
Autor:
Yukiko Yamagishi, Shin Ichi Sueta, Kenji Osafune, Azusa Hoshina, Yasunori Sato, Hiromi Tanaka, Tatsuya Kawamoto, Toshikazu Araoka, Shin Ichi Mae
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Scientific Reports
Scientific Reports
Cell therapy using renal progenitors differentiated from human embryonic stem cells (hESCs) or induced pluripotent stem cells (hiPSCs) has the potential to significantly reduce the number of patients receiving dialysis therapy. However, the different
Autor:
Tatsuya Kawamoto, Shinya Yamanaka, Toshikazu Araoka, Shin Ichi Sueta, Hiromi Tanaka, Aiko Sato-Otsubo, Kazutoshi Takahashi, Noboru Yamaji, Yasunori Sato, Yukiko Yamagishi, Shin Ichi Mae, Kenji Osafune, Tatsuyuki Inoue, Takafumi Toyohara, Tomoko Kasahara, Seishi Ogawa, Taro Toyoda, Azusa Hoshina
Publikováno v:
Stem cells translational medicine. 4(9):980-992
Acute kidney injury (AKI) is defined as a rapid loss of renal function resulting from various etiologies, with a mortality rate exceeding 60% among intensive care patients. Because conventional treatments have failed to alleviate this condition, the
Autor:
Akira Niwa, Tatsutoshi Nakahata, Shin Ichi Mae, Azusa Hoshina, Maki Kotaka, Naoko Katagiri, Megumu K. Saito, Hirofumi Hitomi, Kenji Osafune, Akira Nishiyama, Takafumi Toyohara, Asadur Rahman, Tomoko Kasahara, Daisuke Nakano
Publikováno v:
Science Translational Medicine. 9
The production of erythropoietin (EPO) by the kidneys, a principal hormone for the hematopoietic system, is reduced in patients with chronic kidney disease (CKD), eventually resulting in severe anemia. Although recombinant human EPO treatment improve
Autor:
Keisuke Nishioka, Hideharu Abe, Makiko Kondo, Toshio Doi, Seiji Kishi, Akira Mima, Rokuro Mimura, Makoto Araki, Hiroya Takeoka, Toshikazu Araoka, Taichi Murakami, Azusa Hoshina, Kojiro Nagai, Masaki Ikeda
Publikováno v:
Journal of Medical Case Reports
Journal of Medical Case Reports, Vol 4, Iss 1, p 322 (2010)
Journal of Medical Case Reports, Vol 4, Iss 1, p 322 (2010)
Introduction Refractory pleural effusion in systemic immunoglobulin light chain amyloidosis without cardiac decompensation is rarely reported and has a poor prognosis in general (a median survival of 1.6 months). Moreover, the optimum treatment for t
Autor:
Makiko Kondo, Shiori Ikemura, Tetsuro Mazaki, Azusa Hoshina, Taichi Murakami, Hideharu Abe, Keisuke Nishioka, Takao Saito, Kazumasa Oka, Kojiro Nagai, Toshio Doi, Rokuro Mimura, Seiji Kishi, Hiroya Takeoka, Toshikazu Araoka, Makoto Araki, Masaki Ikeda, Akira Mima
Publikováno v:
Internal medicine (Tokyo, Japan). 49(16)
Type Iota(a) glycogen storage disease (GSD Iota(a)) is caused by the deficiency of glucose-6-phosphatase activity, which results in metabolic disorder and organ failure, including renal failure. GSD Iota(a) patients are generally diagnosed at a media
Autor:
Hirofumi Hitomi, Tomoko Kasahara, Naoko Katagiri, Azusa Hoshina, Shin-Ichi Mae, Maki Kotaka, Takafumi Toyohara, Rahman, Asadur, Daisuke Nakano, Niwa, Akira, Saito, Megumu K., Tatsutoshi Nakahata, Nishiyama, Akira, Kenji Osafune
Publikováno v:
Science Translational Medicine; 9/27/2017, Vol. 9 Issue 409, p1-15, 15p
Autor:
TAKAFUMI TOYOHARA, SHIN-ICHI MAE, SHIN-ICHI SUETA, TATSUYUKI INOUE, YUKIKO YAMAGISHI, TATSUYA KAWAMOTO, TOMOKO KASAHARA, AZUSA HOSHINA, TARO TOYODA, HIROMI TANAKA, TOSHIKAZU ARAOKA, AIKO SATO-OTSUBO, KAZUTOSHI TAKAHASHI, YASUNORI SATO, NOBORU YAMAJI, SEISHI OGAWA, SHINYA YAMANAKA, KENJI OSAFUNE
Publikováno v:
Stem Cells Translational Medicine; Sep2015, Vol. 4 Issue 9, p980-992, 13p